Jens G Lohr

9PUBLICATIONS
74CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia.

Caroline R M Wiggers, Eugene Y Cho, Merve Ozdemir

|Sep 19, 2025
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma.

Julia Frede, Julia C Poller, Kayleen Shi

|Jul 31, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma.

Tayla B Heavican-Foral, Felix Korell, Irene Scarfò

|Mar 19, 2025
Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia.

Caroline R M Wiggers, Burak Yüzügüldü, Nathanial G Tadros

|Jul 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.

Li Li, Vakul Mohanty, Jinzhuang Dou

|Jun 27, 2022
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy.

Nam Gyu Im, Amy Guillaumet-Adkins, Megha Wal

Pageof 2

Frequent Collaborators

8 joint publications

Birgit Knoechel

6 joint publications

Julia Frede

4 joint publications

Praveen Anand

4 joint publications

Caroline R M Wiggers